EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Long-Term Outcomes of Endoscopic Submucosal Dissection for Special Type of Esophageal Cancer

Yugo Suzuki, Kosuke Nomura, Akira Matsui, Daisuke Kikuchi, Kenichi Ohashi, Shu Hoteya

Digestive Diseases · 2023

DOI: 10.1159/000529590 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Digestive Diseases, 2023. Verfasst von Yugo Suzuki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Esophageal Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Esophageal cancers other than two types, squamous cell carcinoma (SCC) and adenocarcinoma, are commonly referred to as special type of esophageal cancer (STEC). Studies on STECs have been limited because of its low prevalence. Therefore, we aimed to clarify the clinicopathological findings and the long-term outcomes of STECs that were managed with ESD.

Methods

We reviewed 713 patients with 1,089 lesions who underwent ESD for primary esophageal cancer except Barrett’s esophageal cancer. Patients were classified into the SCC group and the STEC group, respectively. Their clinicopathological findings and long-term outcomes including disease-specific survival (DSS) were collected and examined.

Results

A total of 19 consecutive patients (1.7%) were diagnosed with STEC. Nine patients were diagnosed with basaloid carcinoma, 6 with adenosquamous carcinoma, 2 with mucoepidermoid carcinoma, 2 with salivary duct-type carcinoma, and 1 with neuroendocrine cell carcinoma. There was significantly more pT1b esophageal cancer (47.4% vs. 11.0%, p < 0.01) and lymphovascular invasion (31.6% vs. 10.2%, p = 0.011) in the STEC group. Metastatic relapse and disease-specific mortality were significantly higher in the STEC group (both 15.8% vs. 1.2%, p < 0.01), and the STEC group had shorter DSS with 5-year DSS rates of 90.9%. In a subgroup analysis of patients with pT1a esophageal cancer, the 5-year DSS rate was shorter in the STEC group (p < 0.01). In the multivariate analysis, STEC (HR = 0.24) and tumor depth (HR = 12.60) were the factors associated with DSS.

Conclusion

STECs are suggested to have high malignant potential and to be an independent negative prognostic factor for DSS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endoscopic Mucosal ResectionEsophageal NeoplasmsCarcinoma, Squamous CellAdenocarcinomaHumansNeoplasm Recurrence, LocalRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

Endoscopic submucosal dissectionSpecial type of esophageal cancerSuperficial esophageal cancer

Autor:innen und Institutionen

  • Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.
  • Department of Human Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Zitieren

APA

Suzuki, Y., Nomura, K., Matsui, A., Kikuchi, D., Ohashi, K., & Hoteya, S. (2023). Long-Term Outcomes of Endoscopic Submucosal Dissection for Special Type of Esophageal Cancer. Digestive Diseases. https://doi.org/10.1159/000529590

Vancouver

Suzuki Y, Nomura K, Matsui A, Kikuchi D, Ohashi K, Hoteya S. Long-Term Outcomes of Endoscopic Submucosal Dissection for Special Type of Esophageal Cancer. Digestive Diseases. 2023. doi:10.1159/000529590

BibTeX
@article{Suzuki2023,
  author = {Suzuki, Yugo and Nomura, Kosuke and Matsui, Akira and Kikuchi, Daisuke and Ohashi, Kenichi and Hoteya, Shu},
  title = {Long-Term Outcomes of Endoscopic Submucosal Dissection for Special Type of Esophageal Cancer},
  journal = {Digestive Diseases},
  year = {2023},
  doi = {10.1159/000529590}
}
Kostenlos starten →